Literature DB >> 6227068

The quest for an intrinsic C3 activating factor in human glomerular disease.

J L Roberts, E J Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6227068     DOI： 10.1007/BF02918345

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN： 0252-9564


× No keyword cloud information.
  33 in total

1.  Nonimmunoglobulin C3 activating factor in membranoproliferative glomerulonephritis.

Authors:  B G Bartlow; J L Roberts; E J Lewis
Journal:  Kidney Int       Date:  1979-03       Impact factor: 10.612

2.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

3.  The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.

Authors:  U E Nydegger; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.

Authors:  L Halbwachs; M Leveillé; P Lesavre; S Wattel; J Leibowitch
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

5.  C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.

Authors:  R A Thompson
Journal:  Immunology       Date:  1972-01       Impact factor: 7.397

6.  Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection.

Authors:  F Kierszenbaum; J Ivanyi; D B Budzko
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

7.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  A serum C3-activating factor: its characterization and its presence in glomerular deposits.

Authors:  J L Roberts; M Levy; P G Chioros; B G Bartlow; J Forristal; C D West; R Habib; E J Lewis
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.